glp 1 for non obese Are YOU a Slow/Non-Responder to GLP-1's? Researchers find GLP-1 medications safe
Description
Glucagon-like peptide 1 (GLP-1) based therapies have seen a meteoric rise in popularity (about 300%1 increased use between 2018-2023)
Worried about appetite suppressant side effects
Engineering new ligands that specifically target multiple G protein-coupled receptors with desired activity profiles requires time-consuming and expensive cycles of design-make-test-analyse work
Obu Health connects you with licensed providers who assess your health history and create a personalized semaglutide treatment plan if appropriate
Advancing Specialized, Durable, & Efficacious GLP-1s & Investigating Commercial Opportunity to Crystallize Pipeline Strategy & Indication Expansion
